Clinical Study of LV009 Injection for the Treatment of Hematologic and Lymphoid Malignancies

NCT07284927 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

10

Enrollment

INDUSTRY

Sponsor class

Conditions

Non-Hodgkin Lymphoma
Acute Lymphoblastic Leukemia

Interventions

BIOLOGICAL: LV009 Injection

Sponsor

PersonGen BioTherapeutics (Suzhou) Co., Ltd.